Inventor · disambiguated record
Mark C. Poznansky
Also filed as: POZNANSKY MARK · POZNANSKY MARK C
31 granted patents·47 pending applications·315 citations·filing 2000–2024
96Inventor score
Files withMASSACHUSETTS GEN HOSPITAL48GEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL7GEN HOSPITAL CORP6POZNANSKY MARK C6CYTOMATRIX LLC2
Top patents by PatentIndex Score
78 records- 0195US7192769B2Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesCYTOMATRIX LLC·Filed 2002·Granted Mar 20, 2007·67 cites·53 claims
- 0295US6548299B1Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devicesFiled 2000·Granted Apr 15, 2003·72 cites·36 claims
- 0394US6448054B1Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2000·Granted Sep 10, 2002·103 cites·11 claims
- 0488US7775469B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2006·Granted Aug 17, 2010·9 cites·17 claims
- 0587US11325951B2HSP fusion protein with anti-chemorepellant agent for treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted May 10, 2022·2 cites·9 claims
- 0686US7141363B2Purposeful movement of human migratory cells away from an agent sourceGEN HOSPITAL CORP·Filed 2002·Granted Nov 28, 2006·20 cites·13 claims
- 0785US11453706B2HSP fusion protein with anti-chemorepellant agent for treatment of infectious diseaseMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Sep 27, 2022·2 cites·14 claims
- 0885US11364264B2Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Jun 21, 2022·2 cites·14 claims
- 0985US7695712B2Recovery of tissue function following administration of B cells to injured tissueACTX INC·Filed 2006·Granted Apr 13, 2010·13 cites·11 claims
- 1081US11305017B2Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Apr 19, 2022·1 cites·16 claims
- 1180US11718683B2Antigen-binding fusion proteins with modified HSP70 domainsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Aug 8, 2023·2 cites·7 claims
- 1280US9789171B2Anti-fugetactic agents for the treatment of ovarian cancerPOZNANSKY MARK C·Filed 2005·Granted Oct 17, 2017·4 cites·6 claims
- 1379US11890348B2Localized delivery of anti-fugetactic agent for treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Feb 6, 2024·1 cites·16 claims
- 1479US9527906B2Immunotherapies employing self-assembling vaccinesGELFAND JEFFREY A·Filed 2009·Granted Dec 27, 2016·4 cites·15 claims
- 1578US10406217B2Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Sep 10, 2019·1 cites·6 claims
- 1676US7176243B2CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesisBRIGHAM & WOMENS HOSPITAL·Filed 2001·Granted Feb 13, 2007·6 cites·9 claims
- 1776US2023192828A1Immunotherapies employing self-assembling vaccinesMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 1876US2025195466A1CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated DiseaseMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 1976US2020155659A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 2075US2024293564A1Localized delivery of anti-fugetactic agent for treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 2170US2023149347A1CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated DiseaseMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 2269US2022323493A1Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 2369US2022226474A1Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 2467US2021179697A1Immunotherapies employing self-assembling vaccinesMASSACHUSETTS GEN HOSPITAL·Filed 2020·Application pending·0 cites
- 2566US9849094B2Eluting matrix and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Dec 26, 2017·0 cites·16 claims
- 2666US7745578B2Fugetactic proteins, compositions and methods of useGEN HOSPITAL CORP·Filed 2004·Granted Jun 29, 2010·6 cites·2 claims
- 2765US2018099037A1Anti-fugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 2865US2018099034A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 2965US2018099036A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 3065US2018193438A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 3165US2018099035A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 3264US2017319676A1Antifugetactic agents for the treatment of cancersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 3363US2025124570A1Methods for identifying cross-modal features from spatially resolved data setsMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 3461US10800837B2Immunotherapies employing self-assembling vaccinesMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Oct 13, 2020·0 cites·18 claims
- 3561US2023306761A1Methods for identifying cross-modal features from spatially resolved data setsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 3660US10580262B2Eluting matrix and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Mar 3, 2020·0 cites·34 claims
- 3759US9849159B2Eluting matrix and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Dec 26, 2017·0 cites·23 claims
- 3859US2025012798A1Methods for defining stages and progression of amyotrophic lateral sclerosisMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 3958US2016128975A1Antifugetactic agents for the treatment of lung cancerGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4058US2016193311A1Antifugetactic agents for the treatment of skin cancersGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4158US2016166537A1Antifugetactic agents for the treatment of brain cancersGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4258US2016166538A1Antifugetactic agents for the treatment of breast cancerGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4358US2016193312A1Antifugetactic agents for the treatment of liver cancersGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4458US2016184257A1Antifugetactic agents for the treament of pancreas cancerGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4558US2016128976A1Antifugetactic agents for the treatment of cancersGEN HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL·Filed 2015·Application pending·0 cites
- 4657US11547694B2CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated diseaseMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jan 10, 2023·0 cites·13 claims
- 4757US7951364B2CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesisGEN HOSPITAL CORP·Filed 2006·Granted May 31, 2011·0 cites·10 claims
- 4856US11419894B2Modified natural killer cells for the treatment of cancerMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Aug 23, 2022·0 cites·20 claims
- 4956US9775816B2Eluting matrix and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Oct 3, 2017·0 cites·23 claims
- 5056US2023158074A1B cell immunomodulatory therapy for acute respiratory distress syndromeMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark C. Poznansky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →